WALTHAM, Mass., March 22, 2018 /PRNewswire/ -- Respiratory Motion, Inc. reported today that FDA clearance was received for the newest version of its ExSpiron Minute Ventilation (MV) monitoring system ...
OBJECTIVE: We performed a prospective, randomized clinical trial to compare the usefulness of the minute ventilation test (MVT) with clinical judgement in predicting readiness for extubation in ...
Waltham, MA (February 22, 2016) Respiratory Motion, Inc. developer of ExSpiron, the ONLY patient monitor measuring non-invasive Minute Ventilation, critical for early identification of potentially ...
Respiratory Motion, Inc. Receives 510(k) Clearance for ExSpiron™ Monitor, the First Monitor to Provide Continuous Minute Ventilation Data in Non-Ventilated Patients Respiratory Motion, Inc. today ...
Background The increasing number of patients treated by long-term non-invasive ventilation (NIV) challenges the capacity of ...
This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...
Jordan, a 32-year-old man with chronic, poorly controlled asthma, has been in the emergency department for 1 hour with only partial response to aggressive bronchodilator therapy and a single ...
“We have never before been able to quantify the influence of pain agents on the respiratory system with such fidelity,” reported Gary Mullen, M.D., a practicing anesthesiologist at Vidant Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback